Evista (Raloxifene) is one of the most effective SERMs used to treat osteoporosis in women. This drug is similar to Tamoxifen: they both act as anti-estrogens in target tissues. The main difference between them is that Raloxifene is active not only in the breast tissue, but in the uterine and bone tissue as well. It helps prevent bone fragility and keep the normal level of endogenous estradiol. Raloxifene copes better with gynecomastia than Tamoxifen. According to experts, it works 2 times more effective than Tamoxifen. Besides, Raloxifene has a stronger effect in the breast tissue.
No products were found matching your selection.